autoimmune disease

Repertoire pivot pays dividends with Bristol Myers deal
BioPharma Dive
Mon, 04/29/24 - 11:28 am
Bristol Myers Squibb
Repertoire Immune Medicines
vaccines
autoimmune disease
Colorado could cap payments for Amgen’s Enbrel
Stat
Thu, 02/22/24 - 11:47 am
Colorado
Amgen
autoimmune disease
Enbrel
reimbursement
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
Stat
Wed, 02/21/24 - 10:47 pm
CAR-T
New England Journal of Medicine
autoimmune disease
J&J's immune disorder drug succeeds in mid and late-stage studies
Reuters
Mon, 02/5/24 - 10:14 am
JNJ
autoimmune disease
clinical trials
nipocalimab
myasthenia gravis
Sjögren’s syndrome
Kyverna sets IPO range, eyeing $180M haul to fund broad autoimmune CAR-T clinical trial program
Fierce Biotech
Thu, 02/1/24 - 11:19 am
Kyverna Therapeutics
IPOs
cell therapy
autoimmune disease
Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Cour Pharmaceuticals
funding
autoimmune disease
Roche
Pfizer
Bristol Myers Squibb
nanoparticles
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Fierce Biotech
Tue, 01/23/24 - 10:43 am
Roche
Genentech
GenEdit
drug development
gene therapy
autoimmune disease
CRISPR eyes autoimmune disease in revamp of cell therapy plans
BioPharma Dive
Tue, 12/5/23 - 11:38 am
CRISPR Therapeutics
cell therapy
autoimmune disease
cancer
Amgen-backed Seismic shakes up $121M financing for preclinical immunology programs
Fierce Biotech
Mon, 12/4/23 - 10:17 am
Seismic Therapeutic
Amgen Ventures
funding
autoimmune disease
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Fierce Pharma
Mon, 10/2/23 - 11:48 am
Biogen
Roche
Actemra
autoimmune disease
biosimilars
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Benzinga
Thu, 09/21/23 - 11:55 am
Inmagene
Aditum Bio
Celexor
autoimmune disease
inflammatory disease
Hutchmed eyes Chinese approval for autoimmune disorder drug after phase 3 success
Fierce Biotech
Mon, 08/21/23 - 10:36 am
Hutchmed
sovleplenib
China
clinical trials
autoimmune disease
Cartesian maps the path for an autoimmune disease cell therapy
EP Vantage
Fri, 06/23/23 - 09:41 am
Cartesian Therapeutics
MRNA
CAR-T
autoimmune disease
Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics
Fierce Biotech
Tue, 06/20/23 - 11:31 am
Eli Lilly
M&A
DiCE Therapeutics
autoimmune disease
Attovia, a new California biotech, launches with plans to rethink how drugs bind their targets
BioPharma Dive
Tue, 06/20/23 - 11:26 am
Attovia Therapeutics
cancer
autoimmune disease
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Marketwatch
Tue, 05/23/23 - 10:12 am
Immunovant
immunology
IMVT-1402
autoimmune disease
FDA
Here come the PD-1 agonists
EP Vantage
Tue, 05/23/23 - 09:49 am
PD-1 agonists
autoimmune disease
Eli Lilly
rheumatoid arthritis
peresolimab
Magenta agrees to reverse merger with Dianthus after setbacks
BioPharma Dive
Wed, 05/3/23 - 10:48 pm
Magenta Therapeutics
M&A
Dianthus Therapeutics
autoimmune disease
Joe Jimenez's Aditum finds fresh twist on old idea, paying $10M for autoimmune BTK inhibitor
Fierce Biotech
Fri, 04/28/23 - 10:00 am
venture capital
Joe Jimenez
Aditum Bio
autoimmune disease
Regeneron bets on ‘Treg’ cell therapy with Sonoma deal
BioPharma Dive
Tue, 03/28/23 - 10:26 am
Regeneron
Sonoma Biotherapeutics
autoimmune disease
cell therapy
Treg cell therapy

Pages